Cargando…

Association between Mutation in SMARCAD1 and Basan Syndrome with Cutaneous Squamous Cell Carcinoma

BACKGROUND: Basan syndrome is a rare autosomal-dominant ectodermal dysplasia with certain clinic-pathological features caused by mutations in the SMARCAD1 gene. Currently, no skin malignancy related to Basan syndrome has been reported. This study was aimed at identifying related gene mutations in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Ying, Chen, Ting, Yu, Jia, Zhou, He, Lu, Baozhen, Chen, Lijie, Sun, Liwei, Wang, Can, Li, Sujun, Wu, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113868/
https://www.ncbi.nlm.nih.gov/pubmed/35592705
http://dx.doi.org/10.1155/2022/7840710
_version_ 1784709655634640896
author Xiong, Ying
Chen, Ting
Yu, Jia
Zhou, He
Lu, Baozhen
Chen, Lijie
Sun, Liwei
Wang, Can
Li, Sujun
Wu, Bo
author_facet Xiong, Ying
Chen, Ting
Yu, Jia
Zhou, He
Lu, Baozhen
Chen, Lijie
Sun, Liwei
Wang, Can
Li, Sujun
Wu, Bo
author_sort Xiong, Ying
collection PubMed
description BACKGROUND: Basan syndrome is a rare autosomal-dominant ectodermal dysplasia with certain clinic-pathological features caused by mutations in the SMARCAD1 gene. Currently, no skin malignancy related to Basan syndrome has been reported. This study was aimed at identifying related gene mutations in a new Chinese pedigree with Basan syndrome and discovering the possible association between Basan syndrome and cutaneous squamous cell carcinoma (cSCC). METHODS: We report a case of Basan syndrome from China with family history of cSCC. The pedigree contains 28 individuals. Among them, 12 members had Basan syndrome, while 4 affected members were diagnosed with cSCC in the 1st and 2nd generations. Whole exome sequencing (WES) and Sanger sequencing were performed for 7 available individuals. The specific gene mutation on pre-mRNA splicing was also analyzed using in vitro Minigene assay. In addition, sequencing data was analyzed with bioinformatics workflow, aiming to discover the gene associated with cSCC. RESULTS: Gene sequencing results showed a heterozygous mutation, c.378+5G>A, in the SMARCAD1 gene in all tested individuals with Basan syndrome. Minigene result implicated the specific mutation may cause splicing variations by exon skipping occurring in the targeted exons. CONCLUSION: To the best of our knowledge, this is the first study reported Basan syndrome with family history of cSCC. Despite in this study we cannot draw any conclusion about the association between Basan syndrome and cSCC at the genetic level, this study encourages future works to substantiate this potential but important issue.
format Online
Article
Text
id pubmed-9113868
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-91138682022-05-18 Association between Mutation in SMARCAD1 and Basan Syndrome with Cutaneous Squamous Cell Carcinoma Xiong, Ying Chen, Ting Yu, Jia Zhou, He Lu, Baozhen Chen, Lijie Sun, Liwei Wang, Can Li, Sujun Wu, Bo Dis Markers Research Article BACKGROUND: Basan syndrome is a rare autosomal-dominant ectodermal dysplasia with certain clinic-pathological features caused by mutations in the SMARCAD1 gene. Currently, no skin malignancy related to Basan syndrome has been reported. This study was aimed at identifying related gene mutations in a new Chinese pedigree with Basan syndrome and discovering the possible association between Basan syndrome and cutaneous squamous cell carcinoma (cSCC). METHODS: We report a case of Basan syndrome from China with family history of cSCC. The pedigree contains 28 individuals. Among them, 12 members had Basan syndrome, while 4 affected members were diagnosed with cSCC in the 1st and 2nd generations. Whole exome sequencing (WES) and Sanger sequencing were performed for 7 available individuals. The specific gene mutation on pre-mRNA splicing was also analyzed using in vitro Minigene assay. In addition, sequencing data was analyzed with bioinformatics workflow, aiming to discover the gene associated with cSCC. RESULTS: Gene sequencing results showed a heterozygous mutation, c.378+5G>A, in the SMARCAD1 gene in all tested individuals with Basan syndrome. Minigene result implicated the specific mutation may cause splicing variations by exon skipping occurring in the targeted exons. CONCLUSION: To the best of our knowledge, this is the first study reported Basan syndrome with family history of cSCC. Despite in this study we cannot draw any conclusion about the association between Basan syndrome and cSCC at the genetic level, this study encourages future works to substantiate this potential but important issue. Hindawi 2022-05-10 /pmc/articles/PMC9113868/ /pubmed/35592705 http://dx.doi.org/10.1155/2022/7840710 Text en Copyright © 2022 Ying Xiong et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Xiong, Ying
Chen, Ting
Yu, Jia
Zhou, He
Lu, Baozhen
Chen, Lijie
Sun, Liwei
Wang, Can
Li, Sujun
Wu, Bo
Association between Mutation in SMARCAD1 and Basan Syndrome with Cutaneous Squamous Cell Carcinoma
title Association between Mutation in SMARCAD1 and Basan Syndrome with Cutaneous Squamous Cell Carcinoma
title_full Association between Mutation in SMARCAD1 and Basan Syndrome with Cutaneous Squamous Cell Carcinoma
title_fullStr Association between Mutation in SMARCAD1 and Basan Syndrome with Cutaneous Squamous Cell Carcinoma
title_full_unstemmed Association between Mutation in SMARCAD1 and Basan Syndrome with Cutaneous Squamous Cell Carcinoma
title_short Association between Mutation in SMARCAD1 and Basan Syndrome with Cutaneous Squamous Cell Carcinoma
title_sort association between mutation in smarcad1 and basan syndrome with cutaneous squamous cell carcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113868/
https://www.ncbi.nlm.nih.gov/pubmed/35592705
http://dx.doi.org/10.1155/2022/7840710
work_keys_str_mv AT xiongying associationbetweenmutationinsmarcad1andbasansyndromewithcutaneoussquamouscellcarcinoma
AT chenting associationbetweenmutationinsmarcad1andbasansyndromewithcutaneoussquamouscellcarcinoma
AT yujia associationbetweenmutationinsmarcad1andbasansyndromewithcutaneoussquamouscellcarcinoma
AT zhouhe associationbetweenmutationinsmarcad1andbasansyndromewithcutaneoussquamouscellcarcinoma
AT lubaozhen associationbetweenmutationinsmarcad1andbasansyndromewithcutaneoussquamouscellcarcinoma
AT chenlijie associationbetweenmutationinsmarcad1andbasansyndromewithcutaneoussquamouscellcarcinoma
AT sunliwei associationbetweenmutationinsmarcad1andbasansyndromewithcutaneoussquamouscellcarcinoma
AT wangcan associationbetweenmutationinsmarcad1andbasansyndromewithcutaneoussquamouscellcarcinoma
AT lisujun associationbetweenmutationinsmarcad1andbasansyndromewithcutaneoussquamouscellcarcinoma
AT wubo associationbetweenmutationinsmarcad1andbasansyndromewithcutaneoussquamouscellcarcinoma